Apax Partners leads spin-out of biomarker discovery company Sense Proteomic
June 4, 2008
Sense Proteomic spun out of Procognia Ltd by Apax and its management team Maidenhead, UK: June 4, 2008, Sense Proteomic Ltd. today announced its spin out and its creation as a biomarker discovery company. It will now be focussing on using its proprietary protein array platform to discover novel panels of auto-antibody biomarkers in cancer [...]
Invitrogen Receives FDA Clearance for Diagnostic System to Determine Transplant Compatibility
June 3, 2008
CARLSBAD, Calif.--Invitrogen Corporation (NASDAQ:IVGN - News), a provider of essential life science technologies for research, production and diagnostics, today announced it received U.S. Food and Drug Administration (FDA) clearance for its DynaChip™ Antibody Analysis System. The DynaChip™ system is the only automated chip-based system for human leukocyte antigen (HLA) antibody detection and identification. This is [...]
June 3, 2008
Accelerated Technology Laboratories, Inc. (ATL) is pleased to announce that Fred Rider has been promoted to the position of Director of Support Services. Mr. Rider has worked at ATL for 10 years; he is a Microsoft Certified Professional and previously served as ATL's Quality Assurance (QA) Manager and Sr. Software Engineer. Mr. Rider has over [...]
June 3, 2008
MADISON, WI. (June 3, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, announces the new Thermo Scientific Helios™ Zeta double-beam and Helios Omega single-beam UV–Visible spectrophotometers. Designed for research, routine quality control, and teaching needs, these cost-effective instruments offer excellent throughput and affordable analysis of liquid and solid samples. The systems [...]
June 3, 2008
Extech Instruments (www.extech.com), a subsidiary of FLIR Systems, Inc., will launch Canadian distribution of its comprehensive line of test and measurement equipment on June 3rd, 2008. Electrical, environmental/indoor air quality, HVAC/R, mould/moisture remediation, and plant/MRO professionals in Canada will now have a choice when it comes to selecting high-quality test and measurement equipment with built-in [...]
June 3, 2008
AUBAGNE, France & GOETTINGEN, Germany & ST. PAUL, Minn.--Sartorius Stedim Biotech (Paris:DIM) has entered into an agreement with WuXi AppTec, Inc., a wholly owned operating subsidiary of WuXi PharmaTech (NYSE:WX), to cooperate on viral clearance studies. Under this agreement, WuXi AppTec will provide the relevant viruses, materials and methodologies to Sartorius Stedim Biotech to employ [...]
June 3, 2008
Partners Will Co-Develop Genomic Complexity Reduction Methods for Crop Genomes Initial Study to Focus on Wheat Genome BRANFORD, Conn.--454 Life Sciences, a company of Roche, today announced that they will support Cogenics® a subsidiary of Clinical Data, Inc., and Limagrain Verneuil Holding (LVH), a subsidiary of the Limagrain Group, in the development of solutions enabling [...]
CLC bio releases Next Generation Sequencing data analysis solution
June 3, 2008
Thermo Fisher Scientific Introduces New Helios Zeta and Helios Omega UV-Visible Spectrophotometers with USB Storage and Printing Capabilities MADISON, WI. (June 3, 2008) – Thermo Fisher Scientific Inc., the world leader in serving science, announces the new Thermo Scientific Helios™ Zeta double-beam and Helios Omega single-beam UV–Visible spectrophotometers. Designed for research, routine quality control, and [...]
June 3, 2008
FOSTER CITY, Calif. & PALO ALTO, Calif.--Applied Biosystems (NYSE:ABI - News), an Applera Corporation business, and its joint-venture partner, MDS Analytical Technologies, a business unit of MDS Inc. (NYSE:MDZ - News) (TSX:MDS - News), and PREMIER Biosoft International today announced that they have signed a co-marketing and reseller agreement to deliver solutions for glycobiology research [...]
Proteomika and Auguron Partnered up for DNA-Based Protein Chips in Biomarker Discovery
June 3, 2008
Harvard Spin-out Auguron Grants Proteomika Field- Exclusive Rights ZAMUDIO, Spain--Proteomika, a subsidiary of Personalised Medicine leader Progenika Biopharma SA, announced today an option agreement with Auguron Biosciences, Inc, giving them rights to exclusive access in two autoimmune disease areas to use Auguron’s Nucleic Acid Programmable Protein Array (NAPPA) technology. NAPPA technology was developed at the [...]

